Table 2 Knowledge of genotypes included in the vaccine (N = 164)
Bivalent vaccine (Cervarix ® contains VLPs of HPV 16 and 18) | |
• Knowledge of HPV 16 | 1 (0.61) |
• Knowledge of HPV 16 and 18 | 62 (37.8) |
• No knowledge of any of them | 101 (61.6) |
Quadrivalent vaccine (Gardasil® contains VLPs OF HPV 16, 18, 11 y 6) | |
• Knowledge of all of them | 54 (32.9) |
• No knowledge of any them | 99(60.4) |
• Knowledge of HPV 16 and 18 | 5 (3) |
• Knowledge of HPV 11 and 18 | 1 (0.6) |
• Knowledge of HPV 6 and 18 | 1 (0.6) |
• Knowledge of HPV 6, 11 and 18 | 2 (1.22) |
• Knowledge of HPV 11, 16 and 18 | 2 (1.22) |
Global knowledge | |
• Knowledge of every genotypes of both vaccine | 46 (28) |
• Knowledge of the genotypes of bivalent vaccine. | 16 (9.7) |
• Knowledge of the genotypes of quadrivalent vaccine. | 8 (4.8) |
• No knowledge of any of the serotypes | 94 (57.3) |
Value in n (%) or Mean ± ST (Range)) | |